In today’s global health, the biggest problem is lack of resources available to test and treat the great many diseases that inflict the sick and poor. Two key impediments to diagnosis and treatment remain to be resolved: in central labs and facilities, reducing cost while maintaining the same clinical standard; and in resource limited settings, mobile and distributed medical testing. In many diseases such as HIV/AIDS, malaria, tuberculosis, and cancer, currently there are very few diagnostic and monitoring tools available for delivering tests in a rapid, portable, and cost effective manner. These limitations often lead to a great human and financial burden to the healthcare system and a barrier to treatment.
ChipCare’s solution to this problem is an integrated point-of-care testing and monitoring system to address the current clinical challenges in both resource rich and resource limited settings. It combines patient identification, blood testing, communication, and external quality management protocol. It is also a platform system that can be used to test different diseases from a single drop of blood.
ChipCare’s proprietary technology is based on a wide field imaging technique that can test multiple diseases from a single drop of blood. Currently no other POC device offers this functionality. ChipCare has developed a product roadmap which includes a pipeline of products (disposable test slides) to be rolled out after the initial T cell assay launch.
In the News
We look at the technology, the market and or social benefit. The benefit of this innovation is obvious -- it's going to help millions with HIV,
Lino DeFacendis, Director at TIG
"This is a marvellous example of the benefits of research and through technology and knowledge transfer we are able to help launch this innovation for potential commercialization and global use by society."